Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a report released on Monday. The brokerage issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright reissued a “buy” rating and issued a $7.00 price objective on shares of Aethlon Medical in a report on Friday, November 15th.

Aethlon Medical Stock Down 0.4 %

Shares of Aethlon Medical stock opened at $0.63 on Monday. The firm has a market cap of $8.81 million, a P/E ratio of -0.22 and a beta of 1.61. Aethlon Medical has a fifty-two week low of $0.24 and a fifty-two week high of $1.88. The business has a 50-day moving average price of $0.55 and a 200 day moving average price of $0.45.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.